Trauma Devices | Medtech 360 | Market Insights | Japan | 2020
Compared to other major orthopedic markets, the Japanese trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Once the market stabilizes, favorable demographics will support procedure volume expansion, however, overall revenue growth will be hindered by falling ASPs—reflecting biennial MHLW reimbursement cuts—as well as slower entry of premium-priced devices relative to other mature markets globally, and the possible introduction of a cost-effectiveness–based reimbursement pricing system.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in Japan across a 10-year period.
